← Back to Search

Exparel for Post-Surgery Pain Management in Thyroid Conditions

Phase < 1

Waitlist Available

Led By Tabitha Galloway, MD

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients requiring parathyroid/thyroid surgery based on the standard of care

Be older than 18 years old

Must not have

Patients under the age of 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up after surgery, patients will be monitored for two weeks, until they return for their first postoperative appointment.

Awards & highlights

Approved for 20 Other Conditions

All Individual Drugs Already Approved

No Placebo-Only Group

Summary

This trial is testing whether a medication called Exparel can decrease the amount of opioids needed for pain control after surgery.

Who is the study for?

This trial is for English-speaking adults over 18 who need thyroid or parathyroid surgery. It's not open to those under 18, with a history of opioid abuse, or allergies to local anesthetics or opioids.

What is being tested?

The study tests if Exparel, when injected during surgery, reduces the need for opioid painkillers after thyroid and parathyroid surgeries. It aims to improve postoperative pain management.

What are the potential side effects?

Possible side effects may include reactions at the injection site such as swelling and redness, nerve damage symptoms like numbness or tingling, allergic reactions, and low blood pressure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I need surgery for my parathyroid or thyroid as recommended by my doctor.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ after surgery, patients will be monitored for two weeks, until they return for their first postoperative appointment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~after surgery, patients will be monitored for two weeks, until they return for their first postoperative appointment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and after surgery, patients will be monitored for two weeks, until they return for their first postoperative appointment. for reporting.